Resumen de negocios
Ventas por actividad
CAD en millones | 2022 | Peso | 2023 | Peso | Delta |
---|---|---|---|---|---|
Pharmaceutical
96,9
%
| 27 | 96,5 % | 31 | 96,9 % | +13,61 % |
Insecticide
3,1
%
| 1 | 3,5 % | 1 | 3,1 % | -0,21 % |
Ventas por región
CAD en millones | 2022 | Peso | 2023 | Peso | Delta |
---|---|---|---|---|---|
Canada
95,9
%
| 27 | 96,7 % | 30 | 95,9 % | +12,16 % |
Middle East
3,3
%
| 1 | 2,4 % | 1 | 3,3 % | +53,27 % |
United States
0,8
%
| 0 | 0,8 % | 0 | 0,8 % | +7,49 % |
Directores
Directores | Puesto | Edad | Desde |
---|---|---|---|
René Goehrum
CEO | Chief Executive Officer | 64 | 01/01/96 |
Robert March
DFI | Director of Finance/CFO | - | 10/09/18 |
Navid Ashrafi
CTO | Chief Tech/Sci/R&D Officer | - | 01/05/14 |
Neelu Atwal
HRO | Human Resources Officer | - | 01/01/19 |
Corporate Officer/Principal | - | 01/08/15 | |
Kevin Wilson
PRN | Corporate Officer/Principal | - | 01/03/12 |
Administradores
Administradores | Puesto | Edad | Desde |
---|---|---|---|
Sara Elford
BRD | Director/Board Member | 53 | 08/01/18 |
René Goehrum
CEO | Chief Executive Officer | 64 | 01/01/96 |
Peter Lockhard
BRD | Director/Board Member | 60 | 01/06/02 |
Larry Andrews
BRD | Director/Board Member | 71 | 08/01/18 |
Joseph Arcuri
BRD | Director/Board Member | 58 | 29/05/18 |
Stephen Wilton
BRD | Director/Board Member | 63 | 16/01/14 |
Clase de acciones
Vote | Quantity | Flotante | Autocontrol | Total Float | |
---|---|---|---|---|---|
Acción A | 1 | 11 967 052 | 7 257 346 ( 60,64 %) | 175 753 ( 1,469 %) | 60,64 % |
Información de la empresa
![Dirección Biosyent Inc.(RX)](https://cdn.zonebourse.com/static/address/1411555.png)
Ventas por actividad
Ventas por región
Varia. 1 de ene. | Capi. | |
---|---|---|
+55,35 % | 815 mil M | |
+32,07 % | 597 mil M | |
-0,10 % | 377 mil M | |
+15,47 % | 319 mil M | |
+13,10 % | 310 mil M | |
+16,11 % | 247 mil M | |
+13,97 % | 228 mil M | |
+16,54 % | 180 mil M | |
+4,31 % | 170 mil M |